Enovix recently saw an impressive 90% price increase over the last quarter, coinciding with its launch of the AI-1TM platform, a next-gen battery solution designed to enhance energy storage for smartphones. This development aligns with the technology sector’s strength, driven by the S&P 500 and Nasdaq Composite’s recent record highs, reflecting a robust market backdrop. The share repurchase program, announced on July 2, may have bolstered shareholder value, while broader market dynamics, including tariff discussions and tech sector volatility, contributed to fluctuations, yet maintained an upward trajectory in contrast to some tech stocks facing challenges.

We’ve identified 1 risk with Enovix and understanding the impact should be part of your investment process.

NasdaqGS:ENVX Earnings Per Share Growth as at Jul 2025

AI is about to change healthcare. These 25 stocks are working on everything from early diagnostics to drug discovery. The best part – they are all under $10b in market cap – there’s still time to get in early.

The recent surge in Enovix’s share price, attributed to the launch of the AI-1 platform, may signal investor optimism about the company’s future potential. This momentum aligns with the positive growth narrative, particularly with its strategic expansion into defense and smart eyewear markets forecasted to unlock new revenue streams. The share price jump, particularly impressive against the backdrop of recent tech sector volatility, underscores its positioning within a robust market context. Enovix’s total shareholder return over the past three years was 22.47%, offering a longer-term perspective, though it underperformed compared to certain industry peers and market benchmarks over the past year.

Enovix’s focus on next-gen battery solutions is expected to have a significant impact on future revenue and earnings forecasts. Analysts anticipate a substantial increase in revenue at 171.2% annually over three years, although the company’s path to profitability remains challenging, with ongoing EBITDA and EPS losses. If the company’s profit margins align with the industry average, it could see improved earnings and return on equity by 2028. Despite the increase in share price, there’s still a significant gap when compared to the analyst consensus price target of US$26.91, suggesting possible upside potential. However, risks such as delays in high-volume production and customer qualification pose challenges to these optimistic projections.

Gain insights into Enovix’s past trends and performance with our report on the company’s historical track record.